Data / Drug companies / Actipharma, LLC
Actipharma, LLC: 13 products in the FDA NDC directory, labeler code 63102
Actipharma, LLC (labeler code 63102) lists 13 products in the FDA National Drug Code Directory, covering 7 finished drugs by generic name. By type: 13 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on February 12, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 63102
- Products in commercial distribution
- 13
- Packages
- 13
- Finished drugs by generic name
- 7
- Prescription products
- 0
- Over the counter products
- 13
- Flagged as original packager
- 13 of 13 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- September 24, 2014
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 13 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 13 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Dexbrompheniramine maleate, pseudoephedrine hydrochloride | 3 | 1 |
| Dextromethorphan hbr,guaifenesin,pseudoephedrine hcl | 2 | 1 |
| Dextromethorphan hbr, guaifenesin, phenylephrine hcl | 1 | 28 |
| Acetaminophen, dexbrompheniramine maleate | 1 | 3 |
| Dexbrompheniramine maleate, acetaminophen | 1 | 1 |
| Dextromethorphan hydrobromide, guaifenesin | 1 | 49 |
| Chlorpheniramine maleate, phenylephrine hydrochloride | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 8 | 61.5% |
| Tablet | 3 | 23.1% |
| Liquid | 2 | 15.4% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Expectorant | 7 |
| Sigma-1 Agonist | 7 |
| Uncompetitive N-methyl-D-aspartate Receptor Antagonist | 7 |
| alpha-Adrenergic Agonist | 6 |
| alpha-1 Adrenergic Agonist | 4 |
| Histamine-1 Receptor Antagonist | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| ACTINEL Diabetic | 63102-140 | Liquid | Over the counter monograph drugs | February 12, 2026 |
| ACTINEL DM Pediatric | 63102-130 | Liquid | Over the counter monograph drugs | February 12, 2026 |
| Actispec pse | 63102-120 | Solution | Over the counter monograph drugs | July 17, 2025 |
| Acticon pediatric | 63102-109 | Solution | Over the counter monograph drugs | July 17, 2025 |
| Acticon | 63102-108 | Solution | Over the counter monograph drugs | February 15, 2022 |
| Actidom da | 63102-115 | Solution | Over the counter monograph drugs | January 20, 2022 |
| Actidogesic df | 63102-403 | Tablet | Over the counter monograph drugs | July 10, 2020 |
| Actinel dm | 63102-104 | Solution | Over the counter monograph drugs | May 20, 2019 |
| Actidogesic | 63102-402 | Tablet | Over the counter monograph drugs | October 14, 2016 |
| Acticon | 63102-401 | Tablet | Over the counter monograph drugs | August 13, 2015 |
| Actidom dmx | 63102-110 | Solution | Over the counter monograph drugs | August 13, 2015 |
| Actinel pediatric | 63102-102 | Solution | Over the counter monograph drugs | September 24, 2014 |
| Actinel | 63102-101 | Solution | Over the counter monograph drugs | September 24, 2014 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.